Naisargi Patel
Data Scientist Regulatory and Real World Evidence
Johnson & Johnson Innovative Medicine
Sarah S
Director, Health Experience and Applied Evidence
Otsuka Precision Health (OPH)
Charles Makin
Head of RWE
Boehringer-Ingelheim
Edgar Simard
Executive Director, Head of Epidemiology & RWD Strategy
Revolution Medicines
Nick Stefanopoulos
Senior Director, Global Digital Health Lead
Pfizer
Ashwini Thirugnanam
PhD Candidate in Pharmacoeconomics
The Massachusetts College of Pharmacy and Health Sciences | Former Real-World Value and Evidence Intern
Tao Fan
Global E&I, Outcomes Research
Merck
Radha Madhavi Ryali
Senior Manager
Novo Nordisk
Anandaroop Dasgupta
Director, Health Economics Outcomes Research (HEOR), Global Value and Access, Oncology
Gilead Sciences
Prajakta Masurkar
Associate Director, US HEOR
UCB
Janie F. Shelton
Director, Translational Epidemiology, Informatics and Predictive Sciences
Bristol Myers Squibb
Nicholas Howard
Health System Medical Outcomes Science Liaison
Alnylam Pharmaceuticals
Dhanish Revanth
HEOR Consultant & Epidemiologist
APPERTURE HEALTH
Mahesh K. Tawney
Director, Strategic Accounts-East
Disc Medicine
Samuel Dyer
CEO
Medical Science Liaison Society
Joseph Anderson
VP. Market Access
Apogee Therapeutics
Jeanne Pierzynski
Associate Director in Real World Evidence Oncology
Gilead Sciences
Neetu Agashivala
Executive Director, Oncology & Immunology HEOR, International
Novartis
Lisa Albert
Director of Epidemiology, RWE Inflammatory Diseases
Gilead Sciences
Trupti Dhumal-Key
HEOR and Bioinformatics Consultant
APPERTURE HEALTH
Tony Okoro
Global Head, Health Economics and Outcomes Research, Pharma
Alcon
Bashir Kalayeh
National Director, Health Economics and Outcomes Research
Bayer
